XORTX Therapeutics Statistics

Total Valuation

XRTX has a market cap or net worth of $4.33 million. The enterprise value is $2.17 million.

Market Cap	4.33M
Enterprise Value	2.17M

Important Dates

The last earnings date was Friday, November 15, 2024.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

XRTX has 3.22 million shares outstanding. The number of shares has increased by 36.19% in one year.

Current Share Class	3.22M
Shares Outstanding	3.22M
Shares Change (YoY)	+36.19%
Shares Change (QoQ)	+1.08%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	2.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.39, with a Debt / Equity ratio of 0.03.

Current Ratio	7.39
Quick Ratio	7.09
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -17.92% and return on invested capital (ROIC) is -42.68%.

Return on Equity (ROE)	-17.92%
Return on Assets (ROA)	-33.81%
Return on Capital (ROIC)	-42.68%
Revenue Per Employee	n/a
Profits Per Employee	-$245,552
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.79% in the last 52 weeks. The beta is -0.21, so XRTX's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	-50.79%
50-Day Moving Average	1.56
200-Day Moving Average	2.32
Relative Strength Index (RSI)	40.32
Average Volume (20 Days)	16,922

Short Selling Information

The latest short interest is 2,238, so 0.07% of the outstanding shares have been sold short.

Short Interest	2,238
Short Previous Month	390
Short % of Shares Out	0.07%
Short % of Float	0.08%
Short Ratio (days to cover)	0.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.84M
Pretax Income	-3.34M
Net Income	-736,657
EBITDA	-2.77M
EBIT	-2.84M
Earnings Per Share (EPS)	-$0.29

Full Income Statement

Balance Sheet

The company has $2.30 million in cash and $61,468 in debt, giving a net cash position of $2.24 million or $0.69 per share.

Cash & Cash Equivalents	2.30M
Total Debt	61,468
Net Cash	2.24M
Net Cash Per Share	$0.69
Equity (Book Value)	2.13M
Book Value Per Share	0.73
Working Capital	2.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$4.09 million and capital expenditures -$1, giving a free cash flow of -$4.09 million.

Operating Cash Flow	-4.09M
Capital Expenditures	-1
Free Cash Flow	-4.09M
FCF Per Share	-$1.27

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.19%
Shareholder Yield	-36.19%
Earnings Yield	-17.02%
FCF Yield	-94.52%

Analyst Forecast

The average price target for XRTX is $14.00, which is 1,020.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	1,020.00%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 14, 2023. It was a reverse split with a ratio of 0.1111111:1.

Last Split Date	Nov 14, 2023
Split Type	Reverse
Split Ratio	0.1111111:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a